Target intelligence / Profile preview

Mitochondrial uncoupling protein 1 gene promoter (UCP1 promoter)

Target
UCP1 promoter
Molecular classification
Gene locus, Promoter region, Regulatory DNA element, Non-coding DNA
01

Overview

The Mitochondrial uncoupling protein 1 (UCP1) gene promoter is a critical regulatory region of the nuclear genome that controls the expression of UCP1, also known as thermogenin [UniProt P25874]. This genomic locus is primarily active in brown and beige adipose tissue, where it facilitates non-shivering thermogenesis by allowing protons to leak across the inner mitochondrial membrane, bypassing ATP synthase and dissipating energy as heat [PubMed: 24122173]. The promoter contains complex regulatory elements, including response elements for peroxisome proliferator-activated receptor gamma (PPAR-gamma), thyroid hormone receptors, and retinoic acid receptors, which serve as docking sites for transcription factors that drive gene expression [PubMed: 10617604]. Targeting this locus is a significant area of research for treating obesity and type 2 diabetes, as increasing UCP1 expression can enhance systemic energy expenditure and improve insulin sensitivity [PubMed: 32024743]. Drugs like mirabegron and thiazolidinediones indirectly target this region by activating signaling pathways or transcription factors that bind to the promoter to induce 'browning' of white fat [PubMed: 8621422]. Therapeutic challenges include ensuring tissue-specific activation to avoid systemic hyperthermia or cardiovascular side effects associated with broad metabolic stimulation.

Other names
UCP1 genomic locusSLC25A7 promoterThermogenin gene promoterUCP1 regulatory regionUncoupling protein 1 enhancer
02

Mechanism of action

Transcriptional upregulation of UCP1 expression to induce mitochondrial proton leak and dissipate energy as heat in adipose tissue.

03

Biological functions

ThermogenesisEnergy expenditureMetabolic regulationMitochondrial uncouplingAdipocyte differentiation
04

Disease associations

ObesityType 2 diabetesMetabolic syndromeInsulin resistanceDyslipidemia
05

Safety considerations

Risk of systemic hyperthermiaPotential for excessive weight loss or cachexia-like statesOff-target effects in non-adipose tissuesCardiovascular stress associated with systemic metabolic activation
06

Interacting drugs

Mirabegron

4 more in the full profile.

07

Biomarkers

UCP1 mRNA expression levelsBrown adipose tissue (BAT) volume18F-FDG uptake (PET-CT imaging)Resting metabolic rate (RMR)

Beyond the preview

Go deeper on Mitochondrial uncoupling protein 1 gene promoter (UCP1 promoter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial uncoupling protein 1 gene promoter (UCP1 promoter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call